Table 1 Correlation between different expression levels of SET8, SNIP1 K301me1, and MARK4 with clinicopathological parameters of individuals with TNBC.

From: KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

  

SET8

SNIP1 K301me1

MARK4

Parameters

N

Low (n = 55)

High (n = 45)

p

Low (n = 48)

High (n = 52)

p

Low (n = 61)

High (n = 39)

p

Age (years)a

≥56

50

26

24

0.5465

25

25

0.6889

31

19

0.8376

<56

50

29

21

 

23

27

 

30

20

 

Tumor sizes (cm)

≤2

17

10

7

0.8766

9

8

0.8678

13

4

0.2764

>2 + ≤5

67

37

30

 

32

35

 

40

27

 

>5

16

8

8

 

7

9

 

8

8

 

T staging

T1 + T2

81

48

33

0.0771

42

39

0.1114

52

29

0.1759

T3 + T4

19

7

12

 

6

13

 

9

10

 

N staging

N1

29

18

11

0.3638

19

10

0.025

25

4

0.001

N2 + N3

71

37

34

 

29

42

 

36

35

 

AJCC stagingb

II

26

16

10

0.436

17

9

0.0392

19

7

0.1422

III + IV

74

39

35

 

31

43

 

42

32

 

Pathological grading

I

10

9

1

0.0095

7

3

0.225

6

4

0.0032

II

78

43

35

 

37

41

 

53

25

 

III

12

3

9

 

4

8

 

2

10

 
  1. aThe age of 100 individuals with TNBC ranged from 24 to 79 years old, with a median of 56 years old.
  2. bThe clinical staging of the individuals was based on the AJCC staging (8th edition).
Back to article page